Reuters logo
BRIEF-Merit Medical’s Embosphere Microspheres receive FDA 513(f)(2) (de novo) classification
2017年6月22日 / 下午1点33分 / 5 个月前

BRIEF-Merit Medical’s Embosphere Microspheres receive FDA 513(f)(2) (de novo) classification

June 22 (Reuters) - Merit Medical Systems Inc

* Merit medical’s embosphere® microspheres receive fda 513(f)(2) (de novo) classification for prostatic artery embolization indication

* Merit medical systems inc - indication now includes prostatic artery embolization (pae) for symptomatic benign prostatic hyperplasia (bph) Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below